Bibliografia UJ CM

1/9
S. Ferrari, C. Libanati, C.J.F. Lin, J.P. Brown, F. Cosman, E[dward] Czerwiński, L.H. de Gregorio, J. Malouf-Sierra, J.-Y. Reginster, A. Wang, R.B. Wagman, E.M. Lewiecki.
Relationship Between Bone Mineral Density T-score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment.
Journal of Bone and Mineral Research
2019 : Vol. 34, nr 6, s. 1033-1040, il., bibliogr. 31 poz., abstr.
Autor korespondencyjny: S. Ferrari.
p-ISSN: 0884-0431
AZ
ORG
AIF
IF: 5.854
Adres url:
Streszczenie w PubMed:
2/9
N.C. Harvey, E. Biver, J.-M. Kaufman, J. Bauer, J. Branco, M.L. M. L. Brandi, O. Bruyere, V. Coxam, A. Cruz-Jentoft, E[dward] Czerwinski, H. Dimai, P. Fardellone, F. Landi, J.-Y. Reginster, B. Dawson-Hughes, J. A. Kanis, R. Rizzoli, C. Cooper.
The role of calcium supplementation in healthy musculoskeletal ageing.
Osteoporosis International
2017 : Vol. 28, nr 2, s. 447-462, bibliogr. 92 poz., abstr.
Autor korespondencyjny: C. Cooper.
p-ISSN: 0937-941X
AZ
POG
AIF
IF: 3.856
BB: PubMed ; Web of Science Core Collection
PubMed; Web of Science Core Collection
Adres url:
Streszczenie w PubMed:
3/9
P. Miller, N. Pannacciulli, J.P. Brown, E[dward] Czerwinski, B.S. Nedergaard, M.A. Bolognese, J. Malouf, H.G. Bone, J.-Y. Reginster, A. Singer, C. Wang, R.B. Wagman, S.R. Cummings.
A randomized double-blind study of denosumab (DMAb) compared with zoledronic acid (ZOL) in postmenopausal women with osteoporosis previously treated with oral bisphosphonates.
Osteoporosis International
2016 : Vol. 27, suppl. 1, s. 41, abstr. OC4.
WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, 14-17 April 2016, Malaga, Spain.
p-ISSN: 0937-941X
SZZ
SIF
Adres url:
4/9
S. Ferrari, S. Adami, J.P. Brown, F. Cosman, E[dward] Czerwinski, L.H. de Gregorio, J. Malouf, J.-Y. Reginster, N.S. Daizadeh, A. Wang, R.B. Wagman, E. M. Lewiecki.
Relationship Between Total Hip (TH) BMD T-score and Incidence of Nonvertebral Fracture (NVFX) With up to 10 Years of Denosumab (DMAb) Treatment.
Osteoporosis International
2016 : Vol. 27, suppl. 1, s. 48-49, abstr. OC17.
WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, 14-17 April 2016, Malaga, Spain.
p-ISSN: 0937-941X
SZZ
SIF
Adres url:
5/9
H.G. Bone, M.L. Brandi, J.P. Brown, R. Chapurlat, S.R. Cummings, E[dward] Czerwinski, A. Fahrleitner-Pammer, D.L. Kendler, K. Lippuner, J.-Y. Reginster, E. Vittinghoff, N.S. Daizadeh, A. Wang, P. Dakin, R.B. Wagman, S.E. Papapoulos.
Ten years of denosumab (DMAB) treatment in postmenopausal women with osteoporosis: results from the freedom extension trial.
Osteoporosis International
2016 : Vol. 27, suppl. 1, s. 135-136, abstr. P217.
WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, 14-17 April 2016, Malaga, Spain.
p-ISSN: 0937-941X
SZZ
SIF
Adres url:
6/9
C. Roux, S. Papapoulos, K. Lippuner, C.J. Lin, D. Kendler, E.M. Lewiecki, M.L. Brandi, E[dward] Czerwinski, E. Franek, P. Lakatos, C. Mautalen, S. Minisola, J.-Y. Reginster, S. Jensen, N. Daizadeh, A. Wang, M. Gavin, R.B. Wagman, H.G. Bone.
Effect of eight years of denosumab treatment in postmenopausal women with osteoporosis: five-year results from the freedom extension.
Annals of the Rheumatic Diseases
2014 : Vol. 73, suppl. 2, s. 761, abstr. SAT0463
Annual European Congress of Rheumatology, Paris, France, 11-14 June 2014
p-ISSN: 0003-4967
SZZ
SIF
7/9
S. Papapoulos, K. Lippuner, C. Roux, C.J.F. Lin, D.L. Kendler, E.M. Lewiecki, M.L. Brandi, E[dward] Czerwinski, E. Franek, P.L. Lakatos, C. Mautalen, S. Minisola, J.-Y. Reginster, S. Jensen, N. Daizadeh, A. Wang, M. Gavin, R.B. Wagman, H.G. Bone.
Eight years of denosumab treatment in postmenopausal women with osteoporosis: results from the first five years of the FREEDOM extension.
Osteoporosis International
2014 : Vol. 25, suppl. 2, s. S118, abstr. OC21
WCO-IOF-ESCEO, World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Seville, Spain, 2-5 April 2014
p-ISSN: 0937-941X
SZZ
SIF
8/9
P.D. Miller, R.R. Recker, J.-Y. Reginster, B.J. Riss, E[dward] Czerwinski, D. Masanauskaite, A. Kenwright, R. Lorenc, J.A. Stakkestad, P. Lakatos.
Efficacy of monthly oral ibandronate is sustained over 5 years : the MOBILE long-term extension study.
Osteoporosis International
2012 : Vol. 23, nr 6, s. 1747-1756, il., bibliogr. 25 poz., abstr.
p-ISSN: 0937-941X
AZ
ORG
AIF
IF: 4.039
9/9
S Papapoulos, Z Man, D Mellstrom, S Radominski, J.-Y. Reginster, H Resch, J Roman, C Roux, S Cummings, H Bone, R Chapurlat, M Brandi, J Brown, E[dward] Czerwinski, N. Daizadeh, A Grauer, M-A Krieg, C Libanati.
Five-year denosumab treatment of postmenopausal women with osteoporosis: results from the first two years of the FREEDOM trial extension.
Osteoporosis International
2011 : Vol. 22, suppl. 1, s. S107-S108, abstr. OC25
European Congress of Osteoporosis & Osteoarthritis (ECCEO11-IOF)
p-ISSN: 0937-941X
SZZ
SIF
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ